Intraprostatic Injections for LUTS/BPH treatment.
CONCLUSIONS: Intraprostatic injections are still to be considered investigational for the minimally invasive management of LUTS/BPE patients. Emerging data suggest a possible role of new agents in the near future when definitive data of ongoing RCTs will be available.
PMID: 30298711 [PubMed - as supplied by publisher]
Source: Minerva Urologica e Nefrologica - Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research
More News: Benign Prostatic Hyperplasia | Clinical Trials | Databases & Libraries | Lower Endoscopy | Science | Study | Urology & Nephrology